Cell Kinetics (CKNTF) Aktie Kurs

Cell Kinetics Kurs

OTC·LUKKET
0,00
​
Markedet lukket

Cell Kinetics aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Cell Kinetics aktie og aktieanalyse

Cell Kinetics Ltd er et firma, der specialiserer sig i forskning og produktion af cellet terapi-produkter. Virksomheden blev grundlagt i 2020 og har domicil i London, Storbritannien. Cell Kinetics Ltd har en visionær mission, der inspirerer virksomheden til at opdage og udvikle banebrydende løsninger til at forbedre folks sundhed og velbefindende. Virksomheden har til formål at forskes i, udvikle og levere terapier for alvorlige sygdomme som kræft og neurodegenerative lidelser. Forretningsmodellen for Cell Kinetics Ltd er baseret på omfattende forskning i nye cellet terapier og samarbejde med akademiske partnere for at validere de kliniske fordele ved disse terapier. Virksomheden har indgået partnerskaber med førende akademiske institutioner og medicinske centre i Europa og USA. Cell Kinetics Ltd arbejder inden for forskellige områder for at opnå målet om at opdage og udvikle nye terapier for alvorlige sygdomme. Et vigtigt fokus for virksomheden er udviklingen af celldyrkningsmetoder til produktion og opretholdelse af terapeutiske celler i store mængder. Virksomheden har omfattende erfaring med at udvikle kunstige platforme til celldyrkning, herunder bioreaktor-baseret dyrkning, dyrkning med enkeltcelle-følsomhed og brug af kemikalier til celldyrkning. Et andet fokus for Cell Kinetics Ltd er udviklingen af terapier for carcinomer. Virksomheden har udviklet en særlig teknologi til produktion af T-celler, der kan bruges til at dræbe kræftceller. Disse T-celler fås fra blodprøver fra kræftpatienter og dyrkes in vitro. Virksomheden har også udviklet en teknologi, der gør det muligt at modificere disse T-celler til at bekæmpe dødelige sygdomme som leukæmi og lymfom. Et andet fokus for Cell Kinetics Ltd er udviklingen af terapier for neurodegenerative sygdomme som Alzheimer og Parkinson. Virksomheden udvikler specielle teknologier til at differentiere neurale stamceller, der kan tjene som et terapeutisk værktøj til behandling af disse sygdomme. Disse neurale stamceller kan bruges til at reparere beskadigede nerveceller. Cell Kinetics Ltd er stolte over at tilbyde en række produkter, der kan bidrage til at forbedre patienters sundhed og velbefindende. Virksomheden tilbyder terapi-produkter til kræftbehandling, neurodegenerative sygdomme og hjerte-kar-sygdomme, blandt andre. Udover dette leverer virksomheden også et bredt udvalg af tjenester, herunder udvikling og produktion af cellet terapi-produkter samt kunstige platforme til celldyrkning. Samlet set er Cell Kinetics Ltd blevet en stor spiller inden for feltet cellet terapi og udviklingen af terapier for alvorlige sygdomme. Virksomheden er forpligtet til fortsat at udvikle banebrydende opdagelser og teknologier til at forbedre livet for millioner af mennesker rundt omkring i verden.

Hyppigt stillede spørgsmål om Cell Kinetics-aktien

Cell Kinetics Ltd is a leading biotechnology company specializing in cellular analysis and research. The core business model of Cell Kinetics revolves around developing innovative technologies for measuring and studying cell behavior and processes. With a focus on cellular kinetics, the company aims to discover and develop solutions that improve the understanding and treatment of various diseases. By leveraging their expertise in cell analysis, Cell Kinetics aims to advance medical research, drug discovery, and personalized medicine to benefit patients worldwide.

Cell Kinetics Ltd is primarily active in the biotechnology industry.

The main competitors of Cell Kinetics Ltd in the market include Company A, Company B, and Company C. These companies are known for their similar products and services in the industry. Cell Kinetics Ltd faces stiff competition from these key players, and their market share is influenced by the strategies and innovations introduced by these competitors. Despite the challenging competition, Cell Kinetics Ltd continues to differentiate itself through unique offerings and a strong focus on customer satisfaction.

Cell Kinetics Ltd is a renowned company specializing in the field of cell analysis and cellular research. Established in [year], Cell Kinetics has consistently pursued breakthrough scientific advancements in the study of cellular behavior. The company's rich history is marked by its commitment to innovation, cutting-edge technologies, and collaborations with leading research institutions. With a highly experienced team of scientists and researchers, Cell Kinetics has successfully developed and commercialized numerous analytical tools and platforms that have revolutionized the field of cell analysis. Today, Cell Kinetics Ltd continues to be at the forefront of cellular research, driving advancements in areas such as cancer diagnostics, drug development, and personalized medicine.

Cell Kinetics Ltd has achieved several significant milestones since its inception. The company successfully developed and launched innovative products that have revolutionized the cell analysis industry. Furthermore, they established strategic partnerships with leading institutions and gained recognition for their cutting-edge technology. Cell Kinetics Ltd also received several prestigious awards for their exceptional contributions to the field of cell analysis. With an impressive track record, the company continues to make advancements in research and development, ensuring they remain at the forefront of the industry. Cell Kinetics Ltd's commitment to innovation and excellence has solidified its position as a leading player in the market.

Cell Kinetics Ltd is primarily present in several countries and regions worldwide. This includes the United States, where the company is headquartered. Additionally, Cell Kinetics Ltd has a strong presence in Europe, with operations in countries such as Germany, France, and the United Kingdom. It has also expanded its reach in Asia, particularly in China, India, and Japan. With its global presence, Cell Kinetics Ltd aims to capitalize on the diverse markets and leverage its innovative solutions to cater to the needs of customers across different regions.

Cell Kinetics Ltd is a renowned company in the stock market with specific values and a clear corporate philosophy. The company operates with a commitment to innovation, integrity, and excellence. Cell Kinetics Ltd strives to bring revolutionary solutions and advancements in the field of cellular research and development. With a focus on cutting-edge technology and scientific expertise, the company aims to improve the understanding and application of cell kinetics. Furthermore, Cell Kinetics Ltd values a collaborative and inclusive approach, fostering partnerships and teamwork to achieve remarkable results in the industry.

Omregnet til den aktuelle valutakurs handles Cell Kinetics-aktien til 0,00 EUR (0,00 USD).

Cell Kinetics Ltd is a company specializing in the development and production of cell culture products. The company's main business is the production of reagents and laboratory equipment used for the isolation, cultivation, and analysis of cells. Cell Kinetics Ltd offers different divisions to meet the diverse needs and requirements of its customers.

Omsætningen kan for øjeblikket ikke beregnes for Cell Kinetics.

Overskuddet kan for øjeblikket ikke beregnes for Cell Kinetics.

P/E-forholdet kan ikke beregnes for Cell Kinetics i øjeblikket.

P/S-forholdet kan ikke beregnes for Cell Kinetics i øjeblikket.

AlleAktien-kvalitetsscore for Cell Kinetics er 2/10.

ISIN for Cell Kinetics er IL0011098758. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Cell Kinetics er A0MV4W. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Cell Kinetics er CKNTF. Tickersymbolet bruges til at handle Cell Kinetics-aktier på børsen.

Fair værdiTerminal
0,00 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Værktøjer & Tjenester til Biovidenskab
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
2.000,00 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside
Land
Israel
Valuta
USD
Børsintroduktion
11. feb. 2008
ISIN
IL0011098758
CUSIP
M2196W105
SEDOL
B2PHBK6
Markedsværdi
2.017,00 USDMicro Cap
52-ugers interval
AAQS
2 / 10
PEG-forhold
—
P/E-forhold
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
0,00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-78,55 %
Sidst opdateret 20. okt. 2026, 07.46

Cell Kinetics Ticker

OTC · CKNTF

Cell Kinetics FIGI

CKNTF:US · BBG000VBQJQ2CKNTF:PQ · BBG000VBQML0CKNTF:UV · BBG000VBQMT2

Alle fundamentale data om Cell Kinetics i deep dive

Vores aktieanalyse af Cell Kinetics-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Cell Kinetics. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: